The role of mTOR inhibitors in the treatment of hepatocellular carcinoma
Article first published online: 11 AUG 2013
© 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd
Volume 33, Issue 8, pages 1133–1134, September 2013
How to Cite
Liver Int. 2013; 33:1133–1134
- Issue published online: 11 AUG 2013
- Article first published online: 11 AUG 2013
- Accepted manuscript online: 15 MAY 2013 11:05AM EST
- Manuscript Accepted: 2 MAY 2013
- Manuscript Received: 31 MAR 2013
Options for accessing this content:
- If you would like institutional access to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- New Users: Please register, then proceed to purchase the article.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!
Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.